A solid-phase sandwich enzyme immunoassay for serum ferritin is described. The assay procedure was simple, showed good precision, and was suitable for the routine determination of serum ferritin concentration in a clinical laboratory. The assay compared well with a conventional radioimmunoassay for ferritin. The assay was extremely sensitive and had a detection limit of 2·2pg.
Ferritin was first detected in the blood of patients wiith grossly elevated levels due to tumour, severe liver disease, or haemochromatosis.' Sensitive radioimmunoassay (RIA) techniques are now available for the detection of the very low serum ferritin concentrations encountered in healthy subjects and in patients with iron deficiency.2-7 Although RIA is a very sensitive technique for detecting ferritin in serum, compounds labelled with gamma-emitting isotopes have a relatively short shelf-life, are expensive, present a health hazard, and are not always suitable for the routine clinical laboratory. Enzymes present an attractive alternative to radioactive labels in immunoassay. A number of enzyme immunoassay (EIA) methods for serum ferritin have been described,8-13 but these either lack sensitivity or involve complex conjugation or assay procedures.
The objectives of this study were (i) to develop a sensitive solid phase EIA for serum ferritin, and (ii) to compare the EIA with commercially available RIAs for serum ferritin.
Material and methods

REAGENTS
Phosphate buffer saline (PBS) 0·015 mol/l phosphate buffer, pH 7'2, containing 0·15 mol/l NaCl; Albumin/phosphate buffer 0'067 mol/l phosphate buffer, pH 7· 5, containing 5 gil bovine serum albumin; Washing buffer 0·067 rnol/l phosphate buffer, pH 7,5, containing 2 gil bovine serum albumin and 0·5 ml/I Tween 20; tCorrespondence should be addressed to UK.
Carbonate/bicarbonate buffer 0·05 rnol/l carbonate/bicarbonate buffer, pH 9'5 (freshly prepared).
ANTIBODY
Rabbit anti-human ferritin (IgG fraction) was obtained from Dako Immunoglobulin Ltd., Copenhagen F, Denmark.
SOLID SUPPORT
Microtitre plates (MTP) were obtained from Dynatech Labs Ltd, Billingshurst, Sussex. Wells were coated with anti-human ferritin by adding 100 !Jol of antibody solution (5 !Jog/ml in freshly prepared 0·05 mol/l carbonate/bicarbonate buffer, pH 9· 5) to each well and incubating the plate at 4°C overnight. In view of the 'edge effect' demonstrated for MTPs,1416 the outside wells of the plates were not used.
HORSERADISH PEROXIDASE (HRP)
HRP obtained was from Hughes and Hughes Company (Reinheit Zahl (RZ) = 1· 0) purified by gel filtration, to give a HRP preparation with an RZ number greater than 2'8. HRP ASSAY HRP activity was assayed by a colorimetric procedure using 2,3 azino-di-(3-ethyl-benzthiazolenesulfonate) diammonium salt (ABTS; Boehringer Mannheim, W Germany) as chromogen. The substrate solution comprised ABTS (3,0 mol/l) in sodium acetate (0'1 mol/l), sodium dihydrogen phosphate (0'05 mol/l, pH 4'5) containing H 20.
(2'5 mmolfl). 18 17 48 to substrate solution (2' 5 m!) and incubating at 30°C for 5 minutes. The colour developed was measured at 415 nm.
ASSESSMENT OF CONJUGATE
80
EIA for serum ferritin The principle of the assay is shown in the scheme (Fig. 2 ).
Optimisation
Each step in the assay was optimised in turn with respect to incubation period and incubation temperature. A compromise was made on certain of the incubation periods in order that the assay could be completed within one working day.
PREPARATION OF FERRITIN
Human spleen ferritin was prepared from human spleen, as described by Granick.P and was purified by gel chromatography. The purity of the ferritin preparation was assessed by polyacrylamide gel electrophoresis, immunoelectrophoresis, and counter current electrophoresis. The concentration of ferritin was estimated by the method of Lowry et al. 20 A sample of horse spleen ferritin (Koch-Light Laboratories, Colnbrook, Bucks) was also electrophoresed in polyacrylamide gel for comparison.
Ferritin standards
The ferritin preparation was diluted in albumin/ phosphate buffer to give the following concentrations of ferritin: 5, 10, 20, 40, and 50 ng/rnl. Aliquots of the standards were taken and stored at -200C.
Immunological properties
These were assessed by immunoprecipitation using 126I-ferritin polyethylene glycol (PEG), and goat anti-rabbit gamma-globulin obtained from a commercially available RIA kit for serum ferritin (RIA Products Inc, Waverly Oaks, Waltham, Mass 02154, USA). The conjugate was diluted 25,50,100, and 200-fold in albumin/phosphate buffer, and 50 fll portions of each dilution were added to tubes containing the 126I-ferritin (50 fll). After incubation at 37°C for 2l hours goat anti-rabbit globulin in PBS (50 fl!) was added, and the mixture was incubated for a further 30 minutes at room temperature. PEG (250 fl!) was added, and the tubes were centrifuged (1400 g) for 30 minutes. The total radioactivity and that associated with the bound fraction (precipitate) were measured (LKB Wallac Ultragamme, Wallac Oy, Turku, Finland), and the percentage bound was calculated. 20 
PREPARATION OF IgG-HRP CONJUGATE
The procedure was based on the method of Nakane and Kawaoi.P The crude conjugate was purified by gel filtration (Fig. la, b) . A portion of the crude conjugate was applied to an Ultrogel ACA 34 column (LKB, South Croydon) (L: 5 x 85 ern) which had been equilibrated with PBS. Fractions of 3 ml were collected at a flow rate of approximately 0'3 ml/rnin, and the absorbance (A) of each fraction was read at 280 nm (protein) and 403 nm (peroxidase). The molar ratio of HRP to IgG in the fractions was determined according to the following formula:
HRP/IgG = (A 4oa/1' 8 x 40,(00)/ {(A28o-Atoa/RZ)/1'45 x 160,OOO} The purified conjugate (fractions 29-37) was then used in the EIA for ferritin described subsequently. 
Enzyme activity
The enzyme activity of conjugate fractions was measured by adding a 10 fll portion of each fraction
Optimised assay
The coated MTP was washed three times with washing buffer and dried by blotting onto tissue PRECISION STUDIES Three serum pools having low, medium, and high concentrations of ferritin were diluted lo-fold with albumin/phosphate buffer. Within-batch variation was determined by assaying the pools repeatedly during one day. Part of each pool was aliquoted and frozen. Between-batch variation was determined from daily duplicate determinations of serum ferritin concentration of these specimens over a period of two months. paper. The series of ferritin standards (100 Ill) or patient's serum samples diluted 10-fold (100 Ill) in albumin/phosphate buffer were incubated in the coated wells at room temperature for 2 hours, After incubation, the wells were emptied and washed three times with washing buffer. The appropriate dilution of IgG-HRP conjugate (100 Ill; diluted in washing buffer) was added to each well, and incubation was continued for 3 hours at room temperature. The MTP was washed and dried as described above. Substrate solution (250 Ill) was added at timed intervals to each well, and colour was allowed to develop for 30 minutes. A sample (200 Ill) of the solution in each well was diluted with 400 III of PBS. The absorbance was measured at 415 nm. A standard curve of the concentration of ferritin (ng/ml) versus absorbance was plotted. Values of the unknown were read directly from the standard curve. Linpisarn, Kricka, Kennedy, and Whitehead low, medium, or high level of ferritin. The samples were diluted lo-fold with albumin/phosphate buffer and assayed for ferritin, and the percentage recovery was calculated.
EFFECT OF BATCH-TO-BATCH VARIATION AND METHOD OF PURIFICATION OF THE CONJUGATE ON THE ASSAY
Two batches of HRP anti-ferritin conjugate were prepared according to the method described previously (see above). Batch-to-batch variation in the conjugate was investigated by comparing the standard curves for ferritin concentration obtained using each conjugate.
COMPARISON OF EIA AND RIA FOR FERRITIN
The EIA was compared with two commercially available RIA kits for serum ferritin. RIA-Gnost-Ferritin was obtained from Hoechst UK Ltd., Salisbury Rd., Hounslow TW4 6JH, and Ferritin 125 1 kit from RIA Products Inc, Waverly Oaks, Waltham, Mass 02154, USA. Duplicate assays of serum samples were performed using the two RIA kits and the EIA procedure described above. Figure la and b compares gel filtration curves for two different batches of crude conjugate. Although the two batches of conjugate were prepared under the same conditions, marked differences in the relative proportions of high molecular weight conjugate (fractions 28-30) to unreacted antibody (fractions 30-40) were discernible.
Results
CONJUGATE
The molar ratio of HRP to IgG in the conjugate was calculated to be approximately 3: 1. Immunoprecipitation with 125I-ferritin was used for this particular study since ferritin fragmented when exposed to 1251-1abelling reagents under our reaction conditions. Other workers have reported similar problems when attempting to label ferritin with 125 1 (D J Goldie, personal communication). FERRITIN Disc polyacrylamide electrophoresis of the spleen ferritin preparation gave a single sharp band in the same position as horse spleen ferritin. Immunoelectrophoresis and counter-current electrophoresis against rabbit anti-human ferritin gave a single precipitin line, indicating that the preparation was pure and confirming its identity as ferritin.
RECOVERY STUDIES
A ferritin solution (100 ng/rnl) was added to an equal volume of a human serum having either a
CONCENTRATION OF SOLID-PHASE IgG
The standard curve for the ferritin assay was unchanged when the concentration of IgG used to Precision offerritin assay Concentration (ng/ml) and SD coat the wells of the MTP was varied in the range 5-20 ng/ml. An IgG concentration of 5 ng/rn! was thus used for the assay. The standard curves for ferritin obtained with the two different batches of conjugate were comparable.
ferritin giving a response distinguishable from the response in the absence of ferritin,21) as calculated from the 95 % confidence limits at the zero point of the standard curve, was 1· 2 ng/rnl. Since 10 III of serum is used in the assay this translates to an absolute sensitivity of 12 pg. Sensitivity could be increased if the conjugate concentration in the assay was increased; it was 0·22 ngjrnl (2,2 pg of ferritin) for 50-fold dilutions of conjugate ( Fig. 3) .
Measures of the within-batch and between-batch precision of the assay at three different ferritin concentrations are given in the Table. The precision of the assay was adequate and similar to that of other published EIAs for ferritin.P 12
Analytical recoveries of various amounts of ferritin were in the range 88-110%.
·No. of detenninations.
CONJUGATE DILUTION
Increasing the concentration of the conjugate (200-to 50-fold dilution) improved the sensitivity of the assay. A l00-fold dilution of the conjugate was chosen for the assay as this dilution represented a balance between sensitivity and economy of reagent (Fig. 3) .
INCUBATION TIME AND TEMPERATURE
Sensitivity of the assay, as judged by the standard curve, increased with the time of incubation between 30 minutes and 2 hours at room temperature. Similarly, sensitivity increased with the time of incubation with conjugate between 1 and 12 hours. There was little difference in sensitivity when the assay was carried out at 4°C as compared with room temperature. Incubation times of 2 hours with sample and 3 hours with conjugate, both at room temperature, were chosen as these resulted in adequate sensitivity and allowed the assay to be completed within one working day.
HRP ASSAY
This was investigated with respect to pH (range 3·0-6·0), concentration of peroxide (range 0,625-10·0 mol/I), and concentration of substrate ABTS (range 0,5-5,0 mmol/l), The optimal pH was 4·5 and the optimal concentrations of peroxide and ABTS were 2·5 mmol/I and 3·0 mmol/l, respectively. The sensitivity and speed of the assay were superior to those of other EIA methods for ferritin reported in the literature.P 12 and the sensitivity compared well with an RIA method for ferritin. However, although the correlation between EIA and RIA for ferritin was good, there was a large bias between the methods. This may be due to: different assigned values for the different standards used in each method (there is no international reference standard for ferritin); differences in the antiferritins used (heterogeneous antibodies to the large complex ferritin molecule are to be expected); or differences in the antigens, which are variously derived from liver and spleen and contain variable amounts of isoferritins. Until these differences have been investigated and resolved, clinical deductions will have to be based on method-specific reference ranges. The EIA method for ferritin developed using polystyrene microtitre plates has proved convenient for large-scale assays. MTPs are easy to handle, relatively inexpensive, and require only small quantities of reagent.P' After being coated with antibody, the plates showed good stability and could be stored for up to four weeks at 4°C. It is, however, important to appreciate the limitations of this type of solid support, for example, 'edge effects', in which wells at the edge of a plate apparently adsorb more antibody than wells towards the centre of the plate. a 15 Thus, in this study, wells at the edge of a plate were not utilised.
An important aspect of the long-term routine utilisation of an EIA is the reproducibility of the coupling procedure used to prepare the conjugate. Little difference was found between EIAs performed using two different batches of purified conjugate,
